Pfizer’s attempt to take over AstraZeneca in May would probably have failed after changes to U.S. tax laws, even if the companies had reached a deal.
Pfizer’s attempt to take over AstraZeneca in May would probably have failed after changes to U.S. tax laws, even if the companies had reached a deal.